BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.07 Billion USD | 490.35% |
| 2022 | -511.06 Million USD | -14.11% |
| 2021 | -447.86 Million USD | 57.62% |
| 2020 | -1.05 Billion USD | -85.28% |
| 2019 | -570.31 Million USD | -11.94% |
| 2018 | -509.49 Million USD | -1330.95% |
| 2017 | -35.6 Million USD | 63.28% |
| 2016 | -96.96 Million USD | -96.15% |
| 2015 | -49.43 Million USD | -460.03% |
| 2014 | -8.82 Million USD | -281.3% |
| 2013 | -2.31 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 626.71 Million USD | 23.89% |
| 2024 Q2 | 767.28 Million USD | 26.22% |
| 2023 Q3 | 684.99 Million USD | 795.34% |
| 2023 Q4 | 505.87 Million USD | -26.15% |
| 2023 FY | 1.99 Billion USD | 490.35% |
| 2023 Q1 | 366.01 Million USD | 362.47% |
| 2023 Q2 | 76.5 Million USD | -79.1% |
| 2022 FY | -511.06 Million USD | -14.11% |
| 2022 Q2 | 270.39 Million USD | 282.05% |
| 2022 Q1 | -148.52 Million USD | 43.96% |
| 2022 Q4 | -139.45 Million USD | -20.97% |
| 2022 Q3 | -115.27 Million USD | -142.63% |
| 2021 Q3 | -192.91 Million USD | 20.4% |
| 2021 Q4 | -265.05 Million USD | -37.4% |
| 2021 FY | -447.86 Million USD | 57.62% |
| 2021 Q1 | 252.46 Million USD | 191.3% |
| 2021 Q2 | -242.36 Million USD | -196.0% |
| 2020 Q3 | -279.11 Million USD | -18.95% |
| 2020 Q4 | -276.51 Million USD | 0.93% |
| 2020 FY | -1.05 Billion USD | -85.28% |
| 2020 Q2 | -234.64 Million USD | 11.92% |
| 2020 Q1 | -266.39 Million USD | -9.02% |
| 2019 FY | -570.31 Million USD | -11.94% |
| 2019 Q4 | -244.35 Million USD | -18.08% |
| 2019 Q1 | -115.77 Million USD | 44.33% |
| 2019 Q2 | -3.25 Million USD | 97.19% |
| 2019 Q3 | -206.93 Million USD | -6261.3% |
| 2018 Q2 | -117.7 Million USD | -44.06% |
| 2018 Q1 | -81.7 Million USD | -7.23% |
| 2018 FY | -509.49 Million USD | -1330.95% |
| 2018 Q4 | -207.98 Million USD | -103.72% |
| 2018 Q3 | -102.09 Million USD | 13.26% |
| 2017 FY | -35.6 Million USD | 63.28% |
| 2017 Q2 | -47.24 Million USD | -10.46% |
| 2017 Q3 | 130.6 Million USD | 376.45% |
| 2017 Q4 | -76.19 Million USD | -158.34% |
| 2017 Q1 | -42.77 Million USD | -139.53% |
| 2016 Q1 | -17.2 Million USD | 26.58% |
| 2016 Q4 | 108.19 Million USD | 459.39% |
| 2016 Q3 | -30.1 Million USD | -45.27% |
| 2016 Q2 | -20.72 Million USD | -20.49% |
| 2016 FY | -96.96 Million USD | -96.15% |
| 2015 FY | -49.43 Million USD | -460.03% |
| 2015 Q2 | -5.35 Million USD | 38.28% |
| 2015 Q1 | -8.68 Million USD | -79.82% |
| 2015 Q3 | -11.97 Million USD | -123.46% |
| 2015 Q4 | -23.42 Million USD | -95.69% |
| 2014 Q3 | -1.91 Million USD | -84.25% |
| 2014 Q4 | -4.82 Million USD | -151.67% |
| 2014 FY | -8.82 Million USD | -281.3% |
| 2014 Q1 | -1.04 Million USD | 0.0% |
| 2014 Q2 | -1.04 Million USD | 0.0% |
| 2013 FY | -2.31 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -5367.085% |
| Alkermes plc | 1.37 Billion USD | -51.225% |
| Agenus Inc. | 139.61 Million USD | -1388.994% |
| Aptorum Group Limited | -1.11 Million USD | 186596.939% |
| Ardelyx, Inc. | 106.66 Million USD | -1849.034% |
| Dyadic International, Inc. | 922.95 Thousand USD | -225138.987% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -9770.657% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1189086.119% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 15662.829% |
| Novavax, Inc. | 639.93 Million USD | -224.854% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 4538.308% |
| Pyxis Oncology, Inc. | -2 Million USD | 104042.95% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 402398.034% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -10816.657% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 4704678.166% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 394570.398% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 2216.598% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -259109.352% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2535293.902% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1436.833% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -26311.625% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 2244.259% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -36.958% |
| AlloVir, Inc. | -398 Thousand USD | 522426.382% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -763.547% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -490196.934% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1705.049% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1732282.5% |
| ChromaDex Corporation | 50.78 Million USD | -3993.854% |
| Chimerix, Inc. | 324 Thousand USD | -641523.148% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 6769.923% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2779.011% |
| CRISPR Therapeutics AG | 240.95 Million USD | -762.755% |
| Precision BioSciences, Inc. | 40.47 Million USD | -5036.536% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 2217.762% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3493.347% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3493.347% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -12440.623% |
| ImmuCell Corporation | 4.39 Million USD | -47186.731% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 2058.915% |
| Immix Biopharma, Inc. | -5468.00 USD | 38018735.699% |
| Incyte Corporation | 3.44 Billion USD | 39.579% |
| Innoviva, Inc. | 261.06 Million USD | -696.299% |
| IO Biotech, Inc. | -756 Thousand USD | 275081.349% |
| Jaguar Health, Inc. | 7.72 Million USD | -26814.28% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 313181.175% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1635.956% |
| ContextLogic Inc. | 59 Million USD | -3423.49% |
| MiMedx Group, Inc. | 266.84 Million USD | -679.057% |
| MEI Pharma, Inc. | 49.32 Million USD | -4114.444% |
| NextCure, Inc. | -3.68 Million USD | 56529.397% |
| Onconetix, Inc. | -1.12 Million USD | 184532.536% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 7276.398% |
| Opthea Limited | 21.72 Thousand USD | -9571074.033% |
| Psyence Biomedical Ltd. | -240.00 USD | 866191350.0% |
| Vaxcyte, Inc. | -75 Million USD | 2871.812% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3626480.7% |
| Precigen, Inc. | 106 Thousand USD | -1961087.736% |
| Pharming Group N.V. | 220.1 Million USD | -844.489% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -403561.942% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -205931.615% |
| PureTech Health plc | -1.6 Million USD | 129785.527% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1793.797% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1245.958% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 4686.562% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 9554.946% |
| Acelyrin, Inc. | -115 Thousand USD | 1807803.478% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 20683206.159% |
| Summit Therapeutics Inc. | -2.05 Million USD | 101507.756% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 364173.38% |
| Senti Biosciences, Inc. | -2.68 Million USD | 77582.631% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -51217.181% |
| Elevation Oncology, Inc. | -39 Thousand USD | 5330507.692% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 43427.616% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 52835.507% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -7036.733% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -419024.798% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3779843.636% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1897.002% |
| Seer, Inc. | 7.02 Million USD | -29483.876% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -47384.217% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -9548.916% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1754544.641% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1450793.994% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -341256.158% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1625.567% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -562.749% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 41577280.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -80663.753% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 4097181.198% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -6974.077% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 896159.914% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 422632.317% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 29387.954% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 438174.155% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 19989128.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -2136204.22% |
| Century Therapeutics, Inc. | -10.8 Million USD | 19332.667% |
| Kura Oncology, Inc. | -849 Thousand USD | 244959.717% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 3197.966% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1414289.796% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1999.031% |
| Autolus Therapeutics plc | -4.86 Million USD | 42813.355% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -4923.097% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1237516.071% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -2094.672% |
| GRI Bio, Inc. | 10.84 Million USD | -19075.897% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -81745.294% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 24030.69% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1082.169% |
| INmune Bio, Inc. | 155 Thousand USD | -1341099.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -3256.301% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 138111.779% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 320686.965% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 7101483.48% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -517029.104% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 104251.253% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 664272.204% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -2100.759% |
| Verastem, Inc. | -62 Thousand USD | 3353098.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -85274.086% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 796597.701% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -68577.205% |
| Histogen Inc. | 3.76 Million USD | -55056.779% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -360700.897% |
| Surrozen, Inc. | -27.23 Million USD | 7734.444% |
| Organovo Holdings, Inc. | -5.38 Million USD | 38675.97% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 172636.601% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 8205.661% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -10267.34% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 104992978.788% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -34168.283% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 3096819.846% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1243.01% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1425729.218% |
| Apollomics, Inc. | 127 Thousand USD | -1636796.85% |
| Amarin Corporation plc | 165.54 Million USD | -1155.797% |
| Mesoblast Limited | -9.81 Million USD | 21280.428% |
| Turnstone Biologics Corp. | 16.5 Million USD | -12494.566% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1981.508% |
| Synaptogenix, Inc. | -6347.00 USD | 32753511.06% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 4076294.118% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1188.296% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -18.274% |
| Better Therapeutics, Inc. | -2.72 Million USD | 76276.585% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1953.46% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -514.9% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18222917.321% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 33308.61% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 187722.653% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -28307.471% |
| Insmed Incorporated | 239.63 Million USD | -767.511% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -58001.146% |
| OmniAb, Inc. | 14.66 Million USD | -14073.717% |
| Alector, Inc. | -95.05 Million USD | 2287.052% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1554.866% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 4883.055% |
| Zai Lab Limited | 170.9 Million USD | -1116.397% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2439.002% |
| Aura Biosciences, Inc. | -1.29 Million USD | 160629.653% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1599022.308% |
| Immunic, Inc. | -111 Thousand USD | 1872945.946% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -13012.52% |
| Veracyte, Inc. | 248.14 Million USD | -737.75% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 129.745% |
| FibroGen, Inc. | 128.9 Million USD | -1512.719% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 368592121.277% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 17918.458% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 38.832% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -534311.054% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -485.026% |
| TG Therapeutics, Inc. | 219.1 Million USD | -848.783% |
| Galecto, Inc. | -830 Thousand USD | 250564.94% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 150198.123% |
| Fortrea Holdings Inc. | 424 Million USD | -390.297% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2512.593% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 366741.799% |
| XBiotech Inc. | -1.74 Million USD | 119300.631% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 187722.653% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 4573.454% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2852.216% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2732.117% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -12271.951% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -434.356% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 4287.28% |
| Vaxxinity, Inc. | -2.23 Million USD | 93155.461% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -536.221% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 18458.248% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -8402.143% |
| NexImmune, Inc. | -1.02 Million USD | 202921.053% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -38497288.889% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 29356.398% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 81.605% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 3110907.009% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 58642.917% |
| Ainos, Inc. | -253.73 Thousand USD | 819409.668% |
| Pluri Inc. | 322 Thousand USD | -645508.385% |
| Prothena Corporation plc | -129.2 Million USD | 1709.012% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -4022.762% |
| Celularity Inc. | 6.75 Million USD | -30675.115% |
| Rallybio Corporation | -150 Thousand USD | 1386006.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 6475.499% |
| MeiraGTx Holdings plc | 287 Thousand USD | -724241.115% |
| Omeros Corporation | -69.77 Million USD | 3079.204% |
| Humacyte, Inc. | -76.55 Million USD | 2815.688% |
| Immunocore Holdings plc | 248.39 Million USD | -736.93% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 13804.654% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -3232.466% |
| Blueprint Medicines Corporation | 236.58 Million USD | -778.698% |
| CalciMedica, Inc. | -58 Thousand USD | 3584339.655% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 145882.539% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -7054.91% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 73196.308% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 6835.328% |
| Pulmatrix, Inc. | -8.22 Million USD | 25390.255% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 177780.256% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 521117.293% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 621.286% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -74798.049% |
| Cytokinetics, Incorporated | -322.59 Million USD | 744.422% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -241037.564% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 609736.07% |
| Vor Biopharma Inc. | -3.49 Million USD | 59632.045% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1803.107% |
| Evogene Ltd. | 1.39 Million USD | -148496.069% |
| ProKidney Corp. | -3.16 Million USD | 65699.842% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4834.148% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -30217.325% |
| CorMedix Inc. | -205.56 Thousand USD | 1011405.105% |
| BioLineRx Ltd. | 1.1 Million USD | -187522.653% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2742.472% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 6299672.727% |
| Atai Life Sciences N.V. | -5000.00 USD | 41577280.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1706054.423% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 2165578.125% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 149765.875% |
| Sagimet Biosciences Inc. | 2 Million USD | -103842.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -212092.344% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2565.469% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2198671.202% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10132.732% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -750.127% |
| Biomea Fusion, Inc. | -4.2 Million USD | 49584.861% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -138.309% |
| Mereo BioPharma Group plc | 7.42 Million USD | -27894.331% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 670699.677% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 17323925.0% |
| Absci Corporation | -41.84 Million USD | 5067.524% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 41577280.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2821.982% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 84572.125% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -872.634% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 221020.191% |
| Allakos Inc. | -6.14 Million USD | 33952.125% |
| Imunon, Inc. | -720 Thousand USD | 288828.412% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 3113.014% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -336.832% |
| BioAtla, Inc. | -103.73 Million USD | 2104.087% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18222917.321% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1167998.315% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 956.135% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 668543.408% |
| XOMA Corporation | 3.86 Million USD | -53742.502% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 3066.197% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -13952.041% |
| aTyr Pharma, Inc. | -2.38 Million USD | 87154.397% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -16584.262% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 7168579.31% |
| Viridian Therapeutics, Inc. | -1 Million USD | 206336.012% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -15991222976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 51971575.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -226.407% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1067580.321% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2734.086% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 7887.739% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -17905662.274% |
| Orgenesis Inc. | -5.72 Million USD | 36411.948% |
| Entera Bio Ltd. | -56 Thousand USD | 3712348.214% |
| GH Research PLC | -315 Thousand USD | 660055.238% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1100025.397% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 396073.143% |
| Xencor, Inc. | -85.26 Million USD | 2538.258% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 940858.088% |
| Replimune Group, Inc. | -2.65 Million USD | 78399.774% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 207729.27% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1068.923% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1067580.321% |
| Portage Biotech Inc. | -54 Thousand USD | 3849838.889% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2198671.202% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 551521.485% |
| OncoCyte Corporation | 413 Thousand USD | -503255.69% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 46248353.615% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 936423072.973% |
| Purple Biotech Ltd. | -196 Thousand USD | 1060742.347% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -23080.854% |
| scPharmaceuticals Inc. | 9.78 Million USD | -21151.881% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 20002.992% |
| HilleVax, Inc. | -2.15 Million USD | 96522.032% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 2143253.608% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 13855465.236% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 311306.437% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 9038617.391% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 27695472.867% |
| Savara Inc. | -44.26 Million USD | 4796.713% |
| Curis, Inc. | 9.81 Million USD | -21089.063% |
| Daré Bioscience, Inc. | 2.76 Million USD | -74962.014% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1666012.588% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 120334.76% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 911880.263% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 74453.84% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 620.152% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3567.194% |
| Erasca, Inc. | -3.73 Million USD | 55803.617% |
| bluebird bio, Inc. | -4.03 Million USD | 51684.591% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7367237.997% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -9.162% |
| DBV Technologies S.A. | 15.72 Million USD | -13117.567% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7367237.997% |
| Moderna, Inc. | 2.15 Billion USD | 3.533% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 227297.705% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -25866.263% |
| Molecular Templates, Inc. | 50.39 Million USD | -4025.129% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 387946.828% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1453.846% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 33511.427% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 5383.936% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1970.689% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 58039.214% |
| MacroGenics, Inc. | 50.52 Million USD | -4014.353% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 34190.833% |
| Prime Medicine, Inc. | -147.9 Million USD | 1505.537% |
| Aditxt, Inc. | -111.66 Thousand USD | 1861875.927% |
| Adagene Inc. | 18.11 Million USD | -11378.122% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -425895.697% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1382.76% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1217.101% |
| SciSparc Ltd. | 2.19 Million USD | -94565.71% |
| Vericel Corporation | 135.57 Million USD | -1433.353% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8299269.628% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 6709992.841% |
| Generation Bio Co. | -73.91 Million USD | 2912.652% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 475811.442% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3706.11% |
| Invivyd, Inc. | -2.02 Million USD | 102607.84% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 791.016% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 2009863.336% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -2057.209% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -2015.069% |
| ADMA Biologics, Inc. | 88.21 Million USD | -2256.502% |
| Clene Inc. | 533 Thousand USD | -389929.831% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -8522.685% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 217326.646% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10132.732% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -104470.372% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1069934.188% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -4073.997% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 29412.733% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 248767.344% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2392.188% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2843289.594% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3810.423% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1300.348% |
| Trevena, Inc. | 1.45 Million USD | -142776.907% |
| Surrozen, Inc. | -27.23 Million USD | 7734.444% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 589011.898% |
| Cingulate Inc. | -582.91 Thousand USD | 356729.749% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 6706096.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 10653.119% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 27461909.775% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 236065.834% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -205.397% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 210510.83% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3689814.6% |
| Kronos Bio, Inc. | 1.37 Million USD | -151420.335% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 3973.698% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 712038.014% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 425821.769% |
| ImmunityBio, Inc. | -17.89 Million USD | 11720.229% |
| Korro Bio, Inc. | -3.63 Million USD | 57368.843% |
| Kineta, Inc. | 5.43 Million USD | -38163.556% |
| BioVie Inc. | -229.37 Thousand USD | 906406.648% |
| Codexis, Inc. | 57.33 Million USD | -3525.875% |
| Celularity Inc. | 6.75 Million USD | -30675.115% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -51703.115% |
| Celcuity Inc. | -142.77 Thousand USD | 1456169.117% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -4109129.097% |
| Cibus, Inc. | 1.42 Million USD | -146092.616% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 555944.652% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 9170.461% |
| IN8bio, Inc. | -2.5 Million USD | 83221.112% |
| Kodiak Sciences Inc. | -25.94 Million USD | 8111.944% |
| Annexon, Inc. | -3.26 Million USD | 63732.048% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 101805.431% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 5080.854% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -324721.719% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -167.029% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1101.965% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 109513.632% |
| Arcellx, Inc. | 108.27 Million USD | -1819.91% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 6522.376% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2524.689% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 9928.191% |
| Moolec Science SA | -143.3 Thousand USD | 1450753.501% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 5012.47% |
| Geron Corporation | -123.5 Million USD | 1783.246% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -63144.874% |
| Royalty Pharma plc | 1.79 Billion USD | -15.885% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 3065.985% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 57554335.88% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -898318.262% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1965.887% |
| Humacyte, Inc. | -76.55 Million USD | 2815.688% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 219117.693% |
| 89bio, Inc. | -273 Thousand USD | 761586.813% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 165482.578% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 245248.467% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1690229.268% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -185678.284% |
| Notable Labs, Ltd. | 113 Thousand USD | -1839598.23% |
| Liquidia Corporation | 14.6 Million USD | -14138.76% |
| Mustang Bio, Inc. | -2.22 Million USD | 93531.865% |
| Immunovant, Inc. | -231 Thousand USD | 900038.961% |
| Quantum-Si incorporated | 488 Thousand USD | -425895.697% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3841.714% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 6929630.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -111546.563% |
| Acasti Pharma Inc. | -11 Thousand USD | 18898818.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1016075.701% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 320686.965% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1341.021% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -183127.185% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 545732.283% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 106272.574% |
| PepGen Inc. | -1.18 Million USD | 175679.307% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1636996.85% |
| United Therapeutics Corporation | 2.07 Billion USD | -0.428% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 9179.176% |
| Solid Biosciences Inc. | -76.56 Million USD | 2815.227% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2517396.538% |
| Immuneering Corporation | -764.13 Thousand USD | 272152.823% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -3137137.414% |
| Belite Bio, Inc | -399 Thousand USD | 521117.293% |
| XOMA Corporation | 3.86 Million USD | -53742.502% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 10475.619% |
| Bionomics Limited | -434.44 Thousand USD | 478604.727% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 193662.291% |
| uniQure N.V. | 2.21 Million USD | -93753.679% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2424.748% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2357.936% |
| Forte Biosciences, Inc. | -9000.00 USD | 23098533.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 249065.15% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 475811.442% |
| Altimmune, Inc. | -65.37 Million USD | 3279.996% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -474.223% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 193662.291% |
| Compugen Ltd. | 31.45 Million USD | -6508.994% |
| Peak Bio, Inc. | 367.76 Thousand USD | -565162.162% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -8379.601% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1924769.444% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2665303.846% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 172906.234% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 114197.64% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1747040.336% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 172906.234% |
| Instil Bio, Inc. | -4.75 Million USD | 43810.24% |
| argenx SE | 1.1 Billion USD | -87.541% |
| Immunome, Inc. | -8.9 Million USD | 23439.609% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 110092.54% |
| Verona Pharma plc | -679.62 Thousand USD | 305983.695% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1188019.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 87263.899% |
| CervoMed Inc. | -1.29 Million USD | 160800.032% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 86467.221% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 43618.087% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -84030.271% |
| Moolec Science SA | -143.3 Thousand USD | 1450753.501% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 509586.802% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 77915.355% |
| AnaptysBio, Inc. | 14.78 Million USD | -13964.4% |
| Design Therapeutics, Inc. | -537 Thousand USD | 387224.581% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 486952.225% |
| NeurAxis, Inc. | 2.15 Million USD | -96290.557% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -96771.342% |
| Lumos Pharma, Inc. | 2 Million USD | -103480.419% |
| Achilles Therapeutics plc | -4.73 Million USD | 44038.738% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1188019.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1967319.304% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -6466.459% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -241037.564% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 201539.826% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 4664.106% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -4834455.814% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 253002.555% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 15799302.006% |
| Palisade Bio, Inc. | 246 Thousand USD | -844964.634% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 6299672.727% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3583.81% |
| Neurogene Inc. | -3.26 Million USD | 63829.583% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1391.986% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 56407.124% |
| Sesen Bio, Inc. | 40 Million USD | -5097.148% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 700052.525% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 51722.545% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 21831.748% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -14664.624% |
| Athira Pharma, Inc. | -969 Thousand USD | 214636.533% |
| Vaccinex, Inc. | -16 Million USD | 13089.621% |
| HCW Biologics Inc. | -574.82 Thousand USD | 361751.392% |
| XOMA Corporation | 3.86 Million USD | -53742.502% |
| Nektar Therapeutics | 53.47 Million USD | -3787.316% |
| Arvinas, Inc. | 71.8 Million USD | -2795.347% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 2590.814% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 3411.603% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 645708.385% |
| Rezolute, Inc. | -36 Thousand USD | 5774708.333% |
| Clene Inc. | 533 Thousand USD | -389929.831% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 161905006.542% |
| BeyondSpring Inc. | 1.75 Million USD | -118624.101% |
| Synlogic, Inc. | -1.92 Million USD | 108148.805% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 5618637.838% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 32931.001% |
| Peak Bio, Inc. | 367.76 Thousand USD | -565162.162% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 11062.712% |
| Krystal Biotech, Inc. | 47.6 Million USD | -4266.892% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1373.417% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -41270.328% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 80389.037% |
| MannKind Corporation | 136.19 Million USD | -1426.429% |
| Ikena Oncology, Inc. | -50.49 Million USD | 4217.205% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1810.47% |
| Gossamer Bio, Inc. | -4.38 Million USD | 47508.415% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 825044.048% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 41577280.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1375.111% |
| Mural Oncology plc | -2.56 Million USD | 81083.989% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 377388.385% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 2078959.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -9916.667% |
| REGENXBIO Inc. | 53.02 Million USD | -3820.23% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 38906.743% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1080728.46% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 120126.501% |
| Vaxart, Inc. | -60.76 Million USD | 3521.258% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 791202.443% |
| Cellectis S.A. | 18 Thousand USD | -11549116.667% |
| Longeveron Inc. | 221 Thousand USD | -940560.181% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2696.302% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -90.199% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 160753.709% |
| Revolution Medicines, Inc. | -399.66 Million USD | 620.152% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 5939697.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -4242469.388% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 75.847% |
| Denali Therapeutics Inc. | -93.34 Million USD | 2327.071% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8299269.628% |
| Veru Inc. | 7.56 Million USD | -27376.59% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1376827.815% |
| Cingulate Inc. | -582.91 Thousand USD | 356729.749% |
| Passage Bio, Inc. | -3.72 Million USD | 55968.288% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 17260636.367% |
| Exicure, Inc. | -1.42 Million USD | 146189.881% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 542883.029% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -76809.323% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 405592.564% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2951.491% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1389646.612% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3611.23% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -531577.494% |
| OmniAb, Inc. | 14.66 Million USD | -14073.717% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -10297.934% |
| Lipocine Inc. | -2.85 Million USD | 73021.491% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 112897.558% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 36539.246% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 138111.779% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2660.182% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 3198344.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -2366.142% |
| Ocugen, Inc. | -33.53 Million USD | 6298.703% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 65845.066% |
| Q32 Bio Inc. | 578 Thousand USD | -359564.187% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 784575.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | 162004.907% |
| Equillium, Inc. | 35.95 Million USD | -5681.353% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 121884.359% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -415107.948% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 50286965.022% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 802748.263% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -491690.865% |
| Dominari Holdings Inc. | 2.03 Million USD | -101854.831% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1133172.257% |
| vTv Therapeutics Inc. | -13.59 Million USD | 15391.35% |
| Bio-Techne Corporation | 773.07 Million USD | -168.908% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -11903.343% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -351.155% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 177932.25% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 8769.137% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -17672.583% |
| Nkarta, Inc. | -5.86 Million USD | 35521.009% |
| BioCardia, Inc. | -7.24 Million USD | 28777.873% |
| Iterum Therapeutics plc | -1.75 Million USD | 118891.943% |